Showing results (81-90 of 217) with videos related to
Sort By:
Pageof 22
The Biochemical Journal|November 15, 1978
Characterization of an Escherichia coli K12 mutant that is sensitive to chlorate when grown aerobicallyG Giordano, L Grillet, R Rosset, et al.The European Respiratory Journal|May 2, 2008
Case volume and mortality in haematological patients with acute respiratory failureL Lecuyer, S Chevret, B Guidet, et al.La Revue De Medecine Interne|March 18, 2015
[Hyperviscosity syndrome]G Dumas, S Merceron, L Zafrani, et al.Antimicrobial Agents and Chemotherapy|June 1, 1991
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumoniaE Azoulay-Dupuis, E Vallée, J P Bedos, et al.Antimicrobial Agents and Chemotherapy|April 29, 1998
Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia modelJ P Bédos, V Rieux, J Bauchet, et al.Nephrologie|January 1, 1990
[Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk]G Steinbach, C Bosc, P L Caraman, et al.Antimicrobial Agents and Chemotherapy|March 30, 2004
Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumoniaE Azoulay-Dupuis, J P Bédos, J Mohler, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1988
Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicityH Mansour, M Levacher, E Azoulay-Dupuis, et al.Antimicrobial Agents and Chemotherapy|December 1, 1992
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumoniaE Azoulay-Dupuis, E Vallee, B Veber, et al.Journal of Cellular Physiology|January 1, 1985
Cultured mouse marrow stromal cell lines. II. Distinct subtypes differing in morphology, collagen types, myelopoietic factors, and leukemic cell growth modulating activitiesD Zipori, D Duksin, M Tamir, et al.Pageof 22